81_FR_78381 81 FR 78166 - Agency Information Collection Activities; Proposed Collection; Comment Request; Potential Tobacco Product Violations Reporting Form

81 FR 78166 - Agency Information Collection Activities; Proposed Collection; Comment Request; Potential Tobacco Product Violations Reporting Form

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 215 (November 7, 2016)

Page Range78166-78167
FR Document2016-26758

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the collection of information contained in FDA's Tobacco Product Violations Reporting Form.

Federal Register, Volume 81 Issue 215 (Monday, November 7, 2016)
[Federal Register Volume 81, Number 215 (Monday, November 7, 2016)]
[Notices]
[Pages 78166-78167]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-26758]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0086]


Agency Information Collection Activities; Proposed Collection; 
Comment Request; Potential Tobacco Product Violations Reporting Form

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
opportunity for public comment on the proposed collection of certain 
information by the Agency. Under the Paperwork Reduction Act of 1995 
(the PRA), Federal Agencies are required to publish notice in the 
Federal Register concerning each proposed collection of information, 
including each proposed extension of an existing collection of 
information, and to allow 60 days for public comment in response to the 
notice. This notice solicits comments on the collection of information 
contained in FDA's Tobacco Product Violations Reporting Form.

DATES: Submit either electronic or written comments on the collection 
of information by January 6, 2017.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to http://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper 
submissions): Division of Dockets Management (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of 
Dockets Management, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2014-N-0086 for ``Agency Information Collection Activities; 
Proposed Collection; Comment Request; Potential Tobacco Product 
Violations Reporting Form.'' Received comments will be placed in the 
docket and, except for those submitted as ``Confidential Submissions,'' 
publicly viewable at http://www.regulations.gov or at the Division of 
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the 
claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on http://www.regulations.gov. 
Submit both copies to the Division of Dockets Management. If you do not 
wish your name and contact information to be made publicly available, 
you can provide this information on the cover sheet and not in the body 
of your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Division of Dockets Management, 5630 Fishers 
Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A63, 11601 
Landsdown St., North Bethesda, MD 20852, [email protected].

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal 
Agencies must obtain approval from the Office of Management and Budget 
(OMB) for each collection of information they conduct or sponsor. 
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes Agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party.

[[Page 78167]]

Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires 
Federal Agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each 
proposed extension of an existing collection of information, before 
submitting the collection to OMB for approval. To comply with this 
requirement, FDA is publishing notice of the proposed collection of 
information set forth in this document.
    With respect to the following collection of information, FDA 
invites comments on these topics: (1) Whether the proposed collection 
of information is necessary for the proper performance of FDA's 
functions, including whether the information will have practical 
utility; (2) the accuracy of FDA's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques, when 
appropriate, and other forms of information technology.

Potential Tobacco Product Violations Reporting Form--OMB Control Number 
0910-0716--Extension

    On June 22, 2009, the President signed the Family Smoking 
Prevention and Tobacco Control Act (the Tobacco Control Act) (Pub. L. 
111-31) into law. The Tobacco Control Act amended section 201 et seq. 
of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 
321 et seq.) by adding a new chapter granting FDA important new 
authority to regulate the manufacture, marketing, and distribution of 
tobacco products to protect the public health generally and to reduce 
tobacco use by minors. FDA is requesting an extension of OMB approval 
for the collection of information to accept consumer and other 
stakeholder feedback and notification of potential violations of the 
FD&C Act, as amended by the Tobacco Control Act.
    FDA created a Tobacco Call Center (with a toll-free number: 1-877-
CTP-1373). Callers are able to report potential violations of the 
Tobacco Control Act, and FDA may conduct followup investigations based 
on information received. When callers report a violation, the caller 
will be asked to provide as much certain information as they can 
recall, including: The date the potential violation occurred; product 
type (e.g., cigarette, smokeless, roll-your-own, cigar, e-cigarette, 
hookah, pipe tobacco); tobacco brand; potential violation type; type of 
potentially violative promotional materials; who potentially violated; 
and the name, address, phone number, and email address of the potential 
violator. The caller will also be asked to list the potential 
violator's Web site (if available), describe the potential violation, 
and provide any additional files or information pertinent to the 
potential violation.
    FDA currently provides a form that may be used to solicit this 
information from the caller (Form FDA 3779, Potential Tobacco Product 
Violations Report), and seeks renewal of Form FDA 3779. This form is 
posted on FDA's Web site. The public and interested stakeholders are 
also able to report information regarding possible violations of the 
Tobacco Control Act through the following methods: Calling the Tobacco 
Call Center using the Center for Tobacco Products' (CTP) toll-free 
number; using a fillable Form FDA 3779 found on FDA's Web site; 
downloading a PDF version of the form to send via email or mail to FDA; 
requesting a copy of Form FDA 3779 by contacting CTP and sending by 
mail to FDA; and sending a letter to FDA's CTP.
    FDA estimates the burden of this collection of information as 
follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                 Number of
         Activity and FDA form 3779              Number of     responses per   Total annual           Average burden per response           Total hours
                                                respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Reporting violations of the FD&C Act, as                 750               2           1,500  0.25 (15 minutes).........................             375
 amended by the Tobacco Control Act via
 telephone, Internet form, mail, smartphone
 application, or email.
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    FDA estimates that submitting the information (by telephone, 
Internet form, paper form by mail, or email) will take 0.25 hour (i.e., 
15 minutes) per response. Based on the type and rate of reporting that 
has been submitted through the Potential Tobacco Violation Reporting 
Form in the past, in addition to the increase that FDA has recently 
experienced in the rate of reporting due to the recent rule, ``Deeming 
Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic 
Act, as Amended by the Family Smoking Prevention and Tobacco Control 
Act,'' FDA estimates the number of annual respondents to this 
collection of information will be 750, who will each submit 2 reports 
by telephone, Internet form, paper form, or email. Each report is 
expected to take 0.25 hour to complete and submit; therefore, total 
burden hours for this collection of information is estimated to be 375 
hours (1,500 responses x 0.25 hour per response).

    Dated: October 27, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-26758 Filed 11-4-16; 8:45 am]
 BILLING CODE 4164-01-P



                                                78166                       Federal Register / Vol. 81, No. 215 / Monday, November 7, 2016 / Notices

                                                1. Guidance for Industry: Internet/Social               in FDA’s Tobacco Product Violations                   between 9 a.m. and 4 p.m., Monday
                                                     Media Platforms with Character Space               Reporting Form.                                       through Friday.
                                                     Limitations—Presenting Risk and Benefit
                                                                                                        DATES: Submit either electronic or                       • Confidential Submissions—To
                                                     Information for Prescription Drugs and                                                                   submit a comment with confidential
                                                     Medical Devices, available at: http://             written comments on the collection of
                                                                                                        information by January 6, 2017.                       information that you do not wish to be
                                                     www.fda.gov/downloads/drugs/guidance
                                                     complianceregulatoryinformation/                                                                         made publicly available, submit your
                                                                                                        ADDRESSES: You may submit comments
                                                     guidances/ucm401087.pdf.                                                                                 comments only as a written/paper
                                                                                                        as follows:
                                                2. https://www.congress.gov/bill/114th-                                                                       submission. You should submit two
                                                     congress/house-bill/2479/text.                     Electronic Submissions                                copies total. One copy will include the
                                                3. http://www.fda.gov/AboutFDA/Centers
                                                                                                          Submit electronic comments in the                   information you claim to be confidential
                                                     Offices/OfficeofMedicalProductsand                                                                       with a heading or cover note that states
                                                     Tobacco/CDER/ucm184250.htm.                        following way:
                                                                                                          • Federal eRulemaking Portal: http://               ‘‘THIS DOCUMENT CONTAINS
                                                4. http://www.politico.com/story/2015/06/at-                                                                  CONFIDENTIAL INFORMATION.’’ The
                                                     the-fda-drugs-and-tweets-dont-mix-                 www.regulations.gov. Follow the
                                                                                                        instructions for submitting comments.                 Agency will review this copy, including
                                                     118693.
                                                5. http://www.dtcperspectives.com/is-one-               Comments submitted electronically,                    the claimed confidential information, in
                                                     click-in-the-cards/.                               including attachments, to http://                     its consideration of comments. The
                                                6. Detlor, B., S. Sproule, and C. Gupta, ‘‘Pre-         www.regulations.gov will be posted to                 second copy, which will have the
                                                     Purchase Online Information Seeking:               the docket unchanged. Because your                    claimed confidential information
                                                     Search Versus Browse.’’ Journal of                 comment will be made public, you are                  redacted/blacked out, will be available
                                                     Electronic Commerce Research, vol. 4,                                                                    for public viewing and posted on http://
                                                     pp. 72–84, 2003.
                                                                                                        solely responsible for ensuring that your
                                                                                                        comment does not include any                          www.regulations.gov. Submit both
                                                7. Pieters, R. and M. Wedel, ‘‘Goal Control of                                                                copies to the Division of Dockets
                                                     Attention to Advertising: The Yarbus               confidential information that you or a
                                                                                                        third party may not wish to be posted,                Management. If you do not wish your
                                                     Implication.’’ Journal of Consumer
                                                     Research, vol. 34, pp. 224–233, 2007.              such as medical information, your or                  name and contact information to be
                                                8. Schlosser, A. E., ‘‘Experiencing Products in         anyone else’s Social Security number, or              made publicly available, you can
                                                     the Virtual World: The Role of Goal and            confidential business information, such               provide this information on the cover
                                                     Imagery in Influencing Attitudes Versus            as a manufacturing process. Please note               sheet and not in the body of your
                                                     Purchase Intentions.’’ Journal of                  that if you include your name, contact                comments and you must identify this
                                                     Consumer Research, vol. 30, pp. 184–                                                                     information as ‘‘confidential.’’ Any
                                                     198, 2003, http://dx.doi.org/10.1086/
                                                                                                        information, or other information that
                                                                                                        identifies you in the body of your                    information marked as ‘‘confidential’’
                                                     376807.                                                                                                  will not be disclosed except in
                                                                                                        comments, that information will be
                                                  Dated: October 31, 2016.                              posted on http://www.regulations.gov.                 accordance with 21 CFR 10.20 and other
                                                Leslie Kux,                                               • If you want to submit a comment                   applicable disclosure law. For more
                                                Associate Commissioner for Policy.                      with confidential information that you                information about FDA’s posting of
                                                [FR Doc. 2016–26793 Filed 11–4–16; 8:45 am]             do not wish to be made available to the               comments to public dockets, see 80 FR
                                                BILLING CODE 4164–01–P                                  public, submit the comment as a                       56469, September 18, 2015, or access
                                                                                                        written/paper submission and in the                   the information at: http://www.fda.gov/
                                                                                                        manner detailed (see ‘‘Written/Paper                  regulatoryinformation/dockets/
                                                DEPARTMENT OF HEALTH AND                                Submissions’’ and ‘‘Instructions’’).                  default.htm.
                                                HUMAN SERVICES                                                                                                   Docket: For access to the docket to
                                                                                                        Written/Paper Submissions                             read background documents or the
                                                Food and Drug Administration                               Submit written/paper submissions as                electronic and written/paper comments
                                                                                                        follows:                                              received, go to http://
                                                [Docket No. FDA–2014–N–0086]                               • Mail/Hand delivery/Courier (for                  www.regulations.gov and insert the
                                                                                                        written/paper submissions): Division of               docket number, found in brackets in the
                                                Agency Information Collection                                                                                 heading of this document, into the
                                                                                                        Dockets Management (HFA–305), Food
                                                Activities; Proposed Collection;                                                                              ‘‘Search’’ box and follow the prompts
                                                                                                        and Drug Administration, 5630 Fishers
                                                Comment Request; Potential Tobacco                                                                            and/or go to the Division of Dockets
                                                                                                        Lane, Rm. 1061, Rockville, MD 20852.
                                                Product Violations Reporting Form                                                                             Management, 5630 Fishers Lane, Rm.
                                                                                                           • For written/paper comments
                                                AGENCY:    Food and Drug Administration,                submitted to the Division of Dockets                  1061, Rockville, MD 20852.
                                                HHS.                                                    Management, FDA will post your                        FOR FURTHER INFORMATION CONTACT: FDA
                                                ACTION:   Notice.                                       comment, as well as any attachments,                  PRA Staff, Office of Operations, Food
                                                                                                        except for information submitted,                     and Drug Administration, Three White
                                                SUMMARY:   The Food and Drug                            marked and identified, as confidential,               Flint North, 10A63, 11601 Landsdown
                                                Administration (FDA) is announcing an                   if submitted as detailed in                           St., North Bethesda, MD 20852,
                                                opportunity for public comment on the                   ‘‘Instructions.’’                                     PRAStaff@fda.hhs.gov.
                                                proposed collection of certain                             Instructions: All submissions received             SUPPLEMENTARY INFORMATION: Under the
                                                information by the Agency. Under the                    must include the Docket No. FDA–                      PRA (44 U.S.C. 3501–3520), Federal
                                                Paperwork Reduction Act of 1995 (the                    2014–N–0086 for ‘‘Agency Information                  Agencies must obtain approval from the
                                                PRA), Federal Agencies are required to                  Collection Activities; Proposed                       Office of Management and Budget
                                                publish notice in the Federal Register                  Collection; Comment Request; Potential                (OMB) for each collection of
sradovich on DSK3GMQ082PROD with NOTICES




                                                concerning each proposed collection of                  Tobacco Product Violations Reporting                  information they conduct or sponsor.
                                                information, including each proposed                    Form.’’ Received comments will be                     ‘‘Collection of information’’ is defined
                                                extension of an existing collection of                  placed in the docket and, except for                  in 44 U.S.C. 3502(3) and 5 CFR
                                                information, and to allow 60 days for                   those submitted as ‘‘Confidential                     1320.3(c) and includes Agency requests
                                                public comment in response to the                       Submissions,’’ publicly viewable at                   or requirements that members of the
                                                notice. This notice solicits comments on                http://www.regulations.gov or at the                  public submit reports, keep records, or
                                                the collection of information contained                 Division of Dockets Management                        provide information to a third party.


                                           VerDate Sep<11>2014   16:02 Nov 04, 2016   Jkt 241001   PO 00000   Frm 00060   Fmt 4703   Sfmt 4703   E:\FR\FM\07NON1.SGM   07NON1


                                                                             Federal Register / Vol. 81, No. 215 / Monday, November 7, 2016 / Notices                                                  78167

                                                Section 3506(c)(2)(A) of the PRA (44                     Potential Tobacco Product Violations                  cigarette, smokeless, roll-your-own,
                                                U.S.C. 3506(c)(2)(A)) requires Federal                   Reporting Form—OMB Control Number                     cigar, e-cigarette, hookah, pipe tobacco);
                                                Agencies to provide a 60-day notice in                   0910–0716—Extension                                   tobacco brand; potential violation type;
                                                the Federal Register concerning each                       On June 22, 2009, the President                     type of potentially violative promotional
                                                proposed collection of information,                      signed the Family Smoking Prevention                  materials; who potentially violated; and
                                                including each proposed extension of an                  and Tobacco Control Act (the Tobacco                  the name, address, phone number, and
                                                existing collection of information,                      Control Act) (Pub. L. 111–31) into law.               email address of the potential violator.
                                                before submitting the collection to OMB                  The Tobacco Control Act amended                       The caller will also be asked to list the
                                                for approval. To comply with this                        section 201 et seq. of the Federal Food,              potential violator’s Web site (if
                                                requirement, FDA is publishing notice                    Drug, and Cosmetic Act (the FD&C Act)                 available), describe the potential
                                                of the proposed collection of                            (21 U.S.C. 321 et seq.) by adding a new               violation, and provide any additional
                                                information set forth in this document.                  chapter granting FDA important new                    files or information pertinent to the
                                                                                                         authority to regulate the manufacture,                potential violation.
                                                   With respect to the following                         marketing, and distribution of tobacco                   FDA currently provides a form that
                                                collection of information, FDA invites                   products to protect the public health                 may be used to solicit this information
                                                comments on these topics: (1) Whether                    generally and to reduce tobacco use by                from the caller (Form FDA 3779,
                                                the proposed collection of information                   minors. FDA is requesting an extension                Potential Tobacco Product Violations
                                                is necessary for the proper performance                  of OMB approval for the collection of                 Report), and seeks renewal of Form FDA
                                                of FDA’s functions, including whether                    information to accept consumer and                    3779. This form is posted on FDA’s Web
                                                the information will have practical                      other stakeholder feedback and                        site. The public and interested
                                                utility; (2) the accuracy of FDA’s                       notification of potential violations of the           stakeholders are also able to report
                                                estimate of the burden of the proposed                   FD&C Act, as amended by the Tobacco                   information regarding possible
                                                collection of information, including the                 Control Act.                                          violations of the Tobacco Control Act
                                                validity of the methodology and                            FDA created a Tobacco Call Center                   through the following methods: Calling
                                                assumptions used; (3) ways to enhance                    (with a toll-free number: 1–877–CTP–                  the Tobacco Call Center using the
                                                the quality, utility, and clarity of the                 1373). Callers are able to report                     Center for Tobacco Products’ (CTP) toll-
                                                information to be collected; and (4)                     potential violations of the Tobacco                   free number; using a fillable Form FDA
                                                ways to minimize the burden of the                       Control Act, and FDA may conduct                      3779 found on FDA’s Web site;
                                                collection of information on                             followup investigations based on                      downloading a PDF version of the form
                                                respondents, including through the use                   information received. When callers                    to send via email or mail to FDA;
                                                of automated collection techniques,                      report a violation, the caller will be                requesting a copy of Form FDA 3779 by
                                                                                                         asked to provide as much certain                      contacting CTP and sending by mail to
                                                when appropriate, and other forms of
                                                                                                         information as they can recall,                       FDA; and sending a letter to FDA’s CTP.
                                                information technology.
                                                                                                         including: The date the potential                        FDA estimates the burden of this
                                                                                                         violation occurred; product type (e.g.,               collection of information as follows:
                                                                                                TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
                                                                                                                                    Number of
                                                                                                                 Number of                            Total annual       Average burden per
                                                              Activity and FDA form 3779                                          responses per                                                    Total hours
                                                                                                                respondents                            responses              response
                                                                                                                                    respondent

                                                Reporting violations of the FD&C Act, as amended                           750                    2           1,500     0.25 (15 minutes) ......            375
                                                  by the Tobacco Control Act via telephone, Inter-
                                                  net form, mail, smartphone application, or email.
                                                   1 There   are no capital costs or operating and maintenance costs associated with this collection of information.


                                                   FDA estimates that submitting the                     complete and submit; therefore, total                 DEPARTMENT OF HEALTH AND
                                                information (by telephone, Internet                      burden hours for this collection of                   HUMAN SERVICES
                                                form, paper form by mail, or email) will                 information is estimated to be 375 hours
                                                take 0.25 hour (i.e., 15 minutes) per                    (1,500 responses × 0.25 hour per                      Food and Drug Administration
                                                response. Based on the type and rate of                  response).
                                                reporting that has been submitted                                                                              [Docket No. FDA–2016–D–0539]
                                                                                                           Dated: October 27, 2016.
                                                through the Potential Tobacco Violation
                                                                                                         Leslie Kux,                                           Clinical Considerations for
                                                Reporting Form in the past, in addition
                                                                                                         Associate Commissioner for Policy.                    Investigational Device Exemptions for
                                                to the increase that FDA has recently
                                                                                                                                                               Neurological Devices Targeting
                                                experienced in the rate of reporting due                 [FR Doc. 2016–26758 Filed 11–4–16; 8:45 am]
                                                                                                                                                               Disease Progression and Clinical
                                                to the recent rule, ‘‘Deeming Tobacco                    BILLING CODE 4164–01–P
                                                                                                                                                               Outcomes; Guidance for Industry and
                                                Products To Be Subject to the Federal
                                                                                                                                                               Food and Drug Administration Staff;
                                                Food, Drug, and Cosmetic Act, as
                                                                                                                                                               Availability
                                                Amended by the Family Smoking
sradovich on DSK3GMQ082PROD with NOTICES




                                                Prevention and Tobacco Control Act,’’                                                                          AGENCY:     Food and Drug Administration,
                                                FDA estimates the number of annual                                                                             HHS.
                                                respondents to this collection of                                                                              ACTION:    Notice of availability.
                                                information will be 750, who will each
                                                submit 2 reports by telephone, Internet                                                                        SUMMARY: The Food and Drug
                                                form, paper form, or email. Each report                                                                        Administration (FDA or Agency) is
                                                is expected to take 0.25 hour to                                                                               announcing the availability of the


                                           VerDate Sep<11>2014    16:02 Nov 04, 2016   Jkt 241001   PO 00000   Frm 00061   Fmt 4703   Sfmt 4703   E:\FR\FM\07NON1.SGM   07NON1



Document Created: 2018-02-14 08:21:24
Document Modified: 2018-02-14 08:21:24
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesSubmit either electronic or written comments on the collection of information by January 6, 2017.
ContactFDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 10A63, 11601 Landsdown St., North Bethesda, MD 20852, [email protected]
FR Citation81 FR 78166 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR